Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women

Pharmacogenetics and Genomics - Tập 16 Số 8 - Trang 547-553 - 2006
Mia M. Gaudet1, Stephen J. Chanock2, Jolanta Lissowska3,2, Sonja I. Berndt2, Alisa M. Goldstein2, Beata Pepłońska4, Louise A. Brinton2, Robert Welch2, Meredith Yeager2, Alicja Bardin‐Mikolajczak5, Mark A. Jenkins2, Thomas R. Sutter6,7, Montserrat García‐Closas2
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland 20852, USA.
2NATIONAL INSTITUTES OF HEALTH
3Maria Sklodowska-Curie Institute of Oncology
4Nofer Institute of Occupational Medicine
5Maria Skłodowska-Curie Institute of Oncology
6Johns Hopkins University
7University of Memphis

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hayes, 1996, 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1, Proc Natl Acad Sci USA, 93, 9776, 10.1073/pnas.93.18.9776

Yager, 2000, Endogenous estrogens as carcinogens through metabolic activation, J Natl Cancer Inst Monogr, 27, 67, 10.1093/oxfordjournals.jncimonographs.a024245

Creveling, 1985, The effect of ring-fluorination on the rate of O-methylation of dihydroxyphenylalanine (DOPA) by catechol-O-methyltransferase: significance in the development of 18F-PETT scanning agents, Biochem Biophys Res Commun, 130, 1123, 10.1016/0006-291X(85)91732-2

Hanna, 2000, Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity, Cancer Res, 60, 3440

Shimada, 1999, Catalytic properties of polymorphic human cytochrome P450 1B1 variants, Carcinogenesis, 20, 1607, 10.1093/carcin/20.8.1607

Wen, 2005, Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis, Cancer Epidemiol Biomarkers Prev, 14, 329, 10.1158/1055-9965.EPI-04-0392

De Vivo, 2002, Association of CYP1B1 polymorphisms and breast cancer risk, Cancer Epidemiol Biomarkers Prev, 11, 489

Bailey, 1998, Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer, Cancer Res, 58, 5038

2005, A candidate gene approach to searching for low-penetrance breast and prostate cancer genes, Nat Rev Cancer, 5, 977, 10.1038/nrc1754

Excoffier, 1995, Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population, Mol Biol Evol, 12, 921

Stram, 2003, Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study, Hum Hered, 55, 27, 10.1159/000071807

Stoilov, 1998, Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1, Am J Hum Genet, 62, 573, 10.1086/301764

Murray, 1997, Tumor-specific expression of cytochrome P450 CYP1B1, Cancer Res, 57, 3026

Packer, 2004, SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes, Nucleic Acids Res, 32, D528, 10.1093/nar/gkh005

Kim, 2004, Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers, Toxicol Appl Pharmacol, 199, 210, 10.1016/j.taap.2003.11.015

Ardlie, 2002, Patterns of linkage disequilibrium in the human genome, Nat Rev Genet, 3, 299, 10.1038/nrg777

Zondervan, 2004, The complex interplay among factors that influence allelic association, Nat Rev Genet, 5, 89, 10.1038/nrg1270

Schaid, 2000, Robust transmission regression models for linkage and association, Genet Epidemiol, 19, S78, 10.1002/1098-2272(2000)19:1+<::AID-GEPI12>3.0.CO;2-A

Schaid, 2002, Score tests for association between traits and haplotypes when linkage phase is ambiguous, Am J Hum Genet, 70, 425, 10.1086/338688

Mammen, 2003, Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against (–)benzo[a]pyrene-7R-trans-7,8-dihydrodiol, Carcinogenesis, 24, 1247, 10.1093/carcin/bgg088

Han, 2003, Functional evaluation of novel single nucleotide polymorphisms and haplotypes in the promoter regions of CYP1B1 and CYP1A1 genes, Mol Carcinog, 37, 158, 10.1002/mc.10132

Risch, 2000, Searching for genetic determinants in the new millennium, Nature, 405, 847, 10.1038/35015718

Tsuchiya, 2005, Cytochrome P450-mediated metabolism of estrogens and its regulation in human, Cancer Lett, 227, 115, 10.1016/j.canlet.2004.10.007

Tsuchiya, 2004, Human CYP1B1 is regulated by estradiol via estrogen receptor, Cancer Res, 64, 3119, 10.1158/0008-5472.CAN-04-0166

Pharoah, 2004, Association studies for finding cancer-susceptibility genetic variants, Nat Rev Cancer, 4, 850, 10.1038/nrc1476

Althuis, 2004, Etiology of hormone receptor-defined breast cancer: a systematic review of the literature, Cancer Epidemiol Biomarkers Prev, 13, 1558, 10.1158/1055-9965.1558.13.10

Rylander-Rudqvist, 2003, Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk, Carcinogenesis, 24, 1533, 10.1093/carcin/bgg114

Modugno, 2003, A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis, Breast Cancer Res Treat, 82, 191, 10.1023/B:BREA.0000004376.21491.44

Morton, 2006, Reporting participation in epidemiologic studies: a survey of practice, Am J Epidemiol, 163, 197, 10.1093/aje/kwj036

Pharoah, 2005, The reliable identification of disease-gene associations, Cancer Epidemiol Biomarkers Prev, 14, 1362, 10.1158/1055-9965.EPI-05-0405

Pritchard, 2001, Are rare variants responsible for susceptibility to complex diseases?, Am J Hum Genet, 69, 124, 10.1086/321272